Navigation Links
NHS Will Do Well to Curb Use Of Umbilical Cord Blood For Treatment of Cancers

should discourage commercial banking of umbilical cord blood. On the contrary, women should be motivated to donate to public// blood banks without the motive of financial gains.

Umbilical cord blood endowed with stem cells are beneficial in treating diseases like childhood leukemia. Bone marrow which is used for treating such diseases is sometimes replaced with cord blood, which is inexpensive and relatively easy to obtain. Also cord blood is not known to spark off any harmful immune response or rejection in the recipient.

For these reasons interest has been growing in banking cord blood as insurance against future disease, but this has worrying implications for NHS services and little chance of benefit, says Dr Leroy Edozien, a Consultant Obstetrician and Gynaecologist at St Mary's Hospital, Manchester.

Cord blood banks generally fall into two groups. Public banks collect cord blood which has been altruistically donated. The blood is used to treat unrelated recipients or is collected from families with a known genetic disease that is treatable by blood stem cell transplantation.

Since 1996, the NHS has been banking donated cord blood through designated public banks run by the National Blood Service and there is universal approval of the storage of this blood.

In contrast, commercial (private) banks operate collection and storage of a baby's cord blood for later use by that person or their siblings should they develop an illness. This 'just-in-case' collection has been criticised by numerous medical bodies and is not recommended.

Scientific arguments against commercial cord blood banking include the chances of the blood being used are very small, the alternatives such as bone marrow, and the speculative claims about how cord blood could be used to treat disease.

But, whatever the scientific merits or demerits, commercial blood banking also raises serious resource, legal, and ethical issues for NHS maternity units, warns the author.

Taking the arguments for and against into consideration, the balance is tilted strongly against NHS trusts collecting cord blood for commercial banking. It should therefore be NHS policy not to facilitate umbilical cord blood collection by its staff, he concludes.



Source-Eurekalert
'"/>




Related medicine news :

1. Umbilical Cord Blood Offers Hope For Patients Who Require Bone Marrow Transplants
2. Umbilical Cord Blood Could Predict Childhood Allergies
3. A Novel System For Clinical Banking Of Umbilical Cord Blood
4. Delay Umbilical Cord Clamping in Pre Term Babies
5. Doctor Dissuades Mothers from Umbilical Cord Banking
6. Umbilical Cord Blood Industry Matures
7. Parents Bank Kids Umbilical Cord Blood
8. Umbilical Cord Blood Banking of Negligible Value: Experts
9. Delayed Cutting of Umbilical Cord Has Benefits
10. Recommendations for Treatment of Blood Pressue
11. Blood Cells Capable of Regenerating Liver
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/9/2016)... ... February 09, 2016 , ... The Bon-Ton Stores, Inc. (NASDAQ: ... stores, announced it has raised $176,000 to benefit the Breast Cancer Research Foundation, ... at the University of Iowa, The Lynn Sage Cancer Research Foundation, and Masonic ...
(Date:2/9/2016)... ... February 09, 2016 , ... METTLER ... ensure lab personnel have a basic understanding of the techniques they use so ... understanding will help them reduce waste and rework to create a leaner overall ...
(Date:2/9/2016)... ... , ... United Methodist Communications collaborated with Chocolate Moose Media ... video designed to prevent the next widespread Ebola outbreak from occurring in ... throughout Togo, Liberia, Sierra Leone, Nigeria, Côte d’Ivoire and other African countries, with ...
(Date:2/9/2016)... ... ... Shark Finds and Kevin Harrington, and the Product Managers of AsSeenOnTV.pro are pleased ... newly patented product that has solved some of the basic problems golfers have faced since ... or right after a rain shower, might understand the struggle of placing the club down ...
(Date:2/8/2016)... ... February 08, 2016 , ... The Federal ... federallabs.org . The site houses a wealth of federal resources that businesses ... the process called technology transfer (T2). As a network of over 300 federal ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... -- Sangamo BioSciences, Inc. (NASDAQ: SGMO ), the ... fourth quarter and full year 2015 financial results ... genome editing," said Edward Lanphier, Sangamo,s president and ... technology leads the therapeutic genome editing field and ... move our ground-breaking genome editing programs through IND ...
(Date:2/9/2016)... 2016 Mast Therapeutics, Inc. (NYSE MKT: ... cell disease and heart failure, today announced that it intends ... common stock in an underwritten public offering.  The offering is ... no assurance as to whether or when the offering may ... of the offering.   --> ...
(Date:2/9/2016)... , Feb. 9, 2016 The global ... 2014, and it is expected to grow with a ... the glass prefilled syringes segment dominated the global prefilled ... --> --> The global market ... rate, due to increasing geriatric population, increasing demand for ...
Breaking Medicine Technology: